AOC3 and neoplasm: Since tumor cells utilize the catalytic activity of VAP-1 to recruit myeloid cells into tumors, and to support tumor progression, small-molecule VAP-1 inhibitors could be an effective immunotherapy for the inhibition of tumor progression [73].